Mechanism of the Blood Pressure Lowering Effect of the DASH Dietary Pattern
2 other identifiers
interventional
20
0 countries
N/A
Brief Summary
Understanding the possible mechanism(s) by which the DASH dietary pattern lowers blood pressure will potentially enhance the value of this dietary intervention by elucidating the conditions under which it will be most effective, identifying target populations, examining its impact on vascular health beyond blood pressure, and enhancing the investigators' understanding of the interactions among diet, blood pressure and vascular function. In addition, results of this study may help to identify additional therapeutic targets. Therefore, the overall goal of the proposed study is to determine the mechanism(s) by which the DASH dietary pattern lowers blood pressure by using a controlled feeding design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2007
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 19, 2009
CompletedFirst Posted
Study publicly available on registry
November 20, 2009
CompletedApril 11, 2013
November 1, 2009
1.9 years
November 19, 2009
April 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
urinary sodium
2 weeks
Secondary Outcomes (1)
blood pressure
2 weeks
Study Arms (2)
DASH
EXPERIMENTALThe Dietary Approaches to Stop Hypertension Dietary pattern.
Control
EXPERIMENTALThe typical American diet as estimated from the NHANES survey.
Interventions
controlled feeding of either the DASH dietary pattern or a typical American diet at isocaloric level.
Eligibility Criteria
You may qualify if:
- SBP 140-159 mm Hg and DBP 90-99 mm Hg based on mean values over two screening visits,
- Age ≥22 years, and
- Willing to eat at least one on-site meal/day, five days/week, and willing to eat study diets and nothing else for the 3 weeks of controlled feeding.
You may not qualify if:
- Any serious illness that would interfere with participation or make DASH diet unsafe to the participants,
- Currently on cancer chemotherapy or with evidence of active malignancy or radiation therapy within past six months,
- History of CVD event (MI, CABG, angioplasty, symptomatic ischemic heart disease, or stroke),
- Clinical diagnosis of congestive heart failure,
- Current diagnosis of diabetes and treatment for diabetes with oral medication or insulin,
- Body mass index \> 45 Kg/m2,
- DASH MECHANISM staff or household member of DASH MECHANISM staff,
- Using Medications including BP lowering drugs within the last three months, using lithium,insulin or oral diabetes medications, oral corticosteroids, unstable doses of psychotropics or phenothiazines, antacids or nutritional supplements unless they can be discontinued, or weight reducing medications;
- Consumption of more than 14 alcoholic drinks per week;
- Investigator discretion for safety or compliance reasons;
- Inability to provide reliable BP \& vascular functions measurements;
- Planning to leave the area prior to the anticipated end of the intervention period;
- Pregnant, planning a pregnancy prior to the end of intervention, or breast feeding;
- Significant food allergies, preferences, or dietary requirements that would interfere with diet adherence; and
- Subjects taking medications for erectile dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- American Heart Associationcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pao-Hwa Lin, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2009
First Posted
November 20, 2009
Study Start
July 1, 2007
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
April 11, 2013
Record last verified: 2009-11